Table 4. Factors associated with immune reconstitution inflammatory in case-control conditional logistic regression univariate and multivariate models in the HIV Outpatient Study, United States, 1996–2007 (N = 1 850).
Baseline factors | OR (95% CI) | P value | Adjusted OR (95% CI) | P value |
---|---|---|---|---|
Age (years) | ||||
35–49 | 0.82 (0.63, 1.07) | 0.14 | 0.68 (0.49, 0.95) | 0.022 |
50+ | 0.65 (0.44, 0.95) | 0.028 | 0.66 (0.42, 1.05) | 0.076 |
18–34 | Referent | Referent | ||
Sex | ||||
Female | 1.72 (1.27, 2.33) | <0.001 | 0.93 (0.58, 1.50) | 0.77 |
Male | Referent | Referent | ||
Race/ethnicity | ||||
White, non-Hispanic | Referent | Referent | ||
All other | 2.45 (1.93, 3.10) | <0.001 | 1.50 (1.11, 2.03) | 0.009 |
HIV risk group | ||||
IDU | 2.50 (1.70, 3.68) | <0.001 | 1.63 (0.96, 2.77) | 0.069 |
HRH | 2.21 (1.67, 2.92) | <0.001 | 1.63 (1.03, 2.56) | 0.036 |
Other/unknown | 1.34 (0.78, 2.31) | 0.29 | 0.69 (0.35, 1.36) | 0.29 |
MSM | Referent | Referent | ||
CD4 cell count (cells/μl)a | ||||
<50 | 7.60 (5.44, 10.60) | <0.001 | 5.01 (3.46, 7.27) | <0.001 |
50–199 | 2.57 (1.87, 3.54) | <0.001 | 2.15 (1.54, 3.02) | <0.001 |
≥200 | Referent | Referent | ||
HIV viral load (log10copies/ml)a | ||||
<4 | Referent | Referent | ||
4-<5 | 1.46 (1.00, 2.14) | 0.050 | 1.32 (0.85, 2.04) | 0.22 |
≥5 | 3.73 (2.58, 5.38) | <0.001 | 2.33 (1.51, 3.61) | <0.001 |
HCV or HBV co-infection | ||||
Yes | 1.38 (0.997, 1.90) | 0.052 | 1.16 (0.76,1.74) | 0.49 |
No | Referent | Referent | ||
TB exposure | ||||
Yes | 1.40 (0.82, 2.36) | 0.22 | 0.96 (0.52,1.80) | 0.90 |
No | Referent | Referent |
CI, confidence interval; HCV, hepatitis C virus; HBV, hepatitis B virus; HRH, high-risk heterosexual; OR, odds ratio; TB, tuberculosis.
Viral load and CD4 cell count values closest to the start of a new or different combination antiretroviral therapy within the preceding 180 days.